Cargando…

Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study

BACKGROUND: The role of the sputum microbiome in chronic obstructive pulmonary disease (COPD) progression remains elusive. As the advent of the new culture-independent microbial sequencing technique makes it possible to disclose the complex microbiome community of the respiratory tract. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Wang, Bingbing, Tan, Min, Song, Xiaolian, Xie, Shuanshuan, Wang, Changhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675190/
https://www.ncbi.nlm.nih.gov/pubmed/36403054
http://dx.doi.org/10.1186/s12931-022-02246-9
_version_ 1784833317050253312
author Li, Wei
Wang, Bingbing
Tan, Min
Song, Xiaolian
Xie, Shuanshuan
Wang, Changhui
author_facet Li, Wei
Wang, Bingbing
Tan, Min
Song, Xiaolian
Xie, Shuanshuan
Wang, Changhui
author_sort Li, Wei
collection PubMed
description BACKGROUND: The role of the sputum microbiome in chronic obstructive pulmonary disease (COPD) progression remains elusive. As the advent of the new culture-independent microbial sequencing technique makes it possible to disclose the complex microbiome community of the respiratory tract. The aim of this study was to use metagenomic next-generation sequencing (mNGS) to confirm whether there are differences in sputum microbiome of COPD between different exacerbation frequencies and lung function. METHODS: Thirty-nine COPD patients were divided into a frequent exacerbators (FE) group (n = 20) and a non-frequent exacerbators (NFE) (n = 19) group according to their exacerbation history, or a mild group (FEV(1)/pre ≥ 50%, n = 20) and a severe group (FEV(1)/pre < 50%, n = 19) according to the lung function. Sputum was collected during their stable phase, followed by DNA extraction, untargeted metagenomic next-generation sequencing (mNGS) and bioinformatic analysis. RESULTS: mNGS identified 3355 bacteria, 71 viruses and 22 fungi at the specie level. It was found that Shannon index and Simpson index in FE group was lower than that in NFE group (p = 0.005, 0.008, respectively) but similar between mild and severe groups. Out of top 10 bacteria taxa, Veillonella, Fusobacterium and Prevotella jejuni had a higher abundance in NFE group, Rothia had a higher abundance in mild group. Linear discriminant analysis revealed that many bacterial taxa were more abundant in NFE group, and they mostly belonged to Actinobacteria, Bacteroidetes and Fusobacteria phyla. Frequency of exacerbations was also found to be negatively correlated with alpha diversity (with Shannon index, r = − 0.423, p = 0.009; with Simpson index, r = − 0.482, p = 0.002). No significant correlation was observed between alpha diversity and FEV(1)/pre. CONCLUSIONS: Microbiome diversity in FE group was lower than that in NFE group. There was a significant difference in microbiome taxa abundance between FE and NFE groups, or mild and severe groups. These findings demonstrated that sputum microbiome community dysbiosis was associated with different exacerbation frequencies and lung function in stable COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02246-9.
format Online
Article
Text
id pubmed-9675190
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96751902022-11-20 Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study Li, Wei Wang, Bingbing Tan, Min Song, Xiaolian Xie, Shuanshuan Wang, Changhui Respir Res Research BACKGROUND: The role of the sputum microbiome in chronic obstructive pulmonary disease (COPD) progression remains elusive. As the advent of the new culture-independent microbial sequencing technique makes it possible to disclose the complex microbiome community of the respiratory tract. The aim of this study was to use metagenomic next-generation sequencing (mNGS) to confirm whether there are differences in sputum microbiome of COPD between different exacerbation frequencies and lung function. METHODS: Thirty-nine COPD patients were divided into a frequent exacerbators (FE) group (n = 20) and a non-frequent exacerbators (NFE) (n = 19) group according to their exacerbation history, or a mild group (FEV(1)/pre ≥ 50%, n = 20) and a severe group (FEV(1)/pre < 50%, n = 19) according to the lung function. Sputum was collected during their stable phase, followed by DNA extraction, untargeted metagenomic next-generation sequencing (mNGS) and bioinformatic analysis. RESULTS: mNGS identified 3355 bacteria, 71 viruses and 22 fungi at the specie level. It was found that Shannon index and Simpson index in FE group was lower than that in NFE group (p = 0.005, 0.008, respectively) but similar between mild and severe groups. Out of top 10 bacteria taxa, Veillonella, Fusobacterium and Prevotella jejuni had a higher abundance in NFE group, Rothia had a higher abundance in mild group. Linear discriminant analysis revealed that many bacterial taxa were more abundant in NFE group, and they mostly belonged to Actinobacteria, Bacteroidetes and Fusobacteria phyla. Frequency of exacerbations was also found to be negatively correlated with alpha diversity (with Shannon index, r = − 0.423, p = 0.009; with Simpson index, r = − 0.482, p = 0.002). No significant correlation was observed between alpha diversity and FEV(1)/pre. CONCLUSIONS: Microbiome diversity in FE group was lower than that in NFE group. There was a significant difference in microbiome taxa abundance between FE and NFE groups, or mild and severe groups. These findings demonstrated that sputum microbiome community dysbiosis was associated with different exacerbation frequencies and lung function in stable COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02246-9. BioMed Central 2022-11-19 2022 /pmc/articles/PMC9675190/ /pubmed/36403054 http://dx.doi.org/10.1186/s12931-022-02246-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Wei
Wang, Bingbing
Tan, Min
Song, Xiaolian
Xie, Shuanshuan
Wang, Changhui
Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
title Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
title_full Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
title_fullStr Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
title_full_unstemmed Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
title_short Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
title_sort analysis of sputum microbial metagenome in copd based on exacerbation frequency and lung function: a case control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675190/
https://www.ncbi.nlm.nih.gov/pubmed/36403054
http://dx.doi.org/10.1186/s12931-022-02246-9
work_keys_str_mv AT liwei analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy
AT wangbingbing analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy
AT tanmin analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy
AT songxiaolian analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy
AT xieshuanshuan analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy
AT wangchanghui analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy